News about Global Pharma

Great Point Partners Announces Acquisition of Lyocontract

Great Point Partners (GPP) has acquired Lyocontract GmbH (Lyocontract), a premium independent drug product contract development and manufacturing organization (CDMO) based in Ilsenburg, Germany.

Global Pharma | 15/06/2024 | By Aishwarya |  565

Novavax Submits Application to FDA for Updated JN.1 COVID-19 Vaccine

Novavax, Inc. has submitted an amendment to its Emergency Use Authorization to the US Food and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine (NVX-CoV2705) for individuals aged 12 and older.

Global Pharma | 15/06/2024 | By Aishwarya |  310

USFDA Grants Approval to Ipsen and Genfit's Drug to Treat Chronic Inflammatory Liver Disease

The French pharmaceutical companies Ipsen and Genfit received fast approval from the US Food and Drug Administration (USFDA) for their medication to treat chronic inflammatory liver disease.

Global Pharma | 14/06/2024 | By Manvi |  580

Bio-Sourcing and Afrigen Biologics to Accelerate Biomanufacturing in South Africa

Bio-Sourcing has signed a partnership agreement with Afrigen Biologics to develop a pilot program in South Africa of a groundbreaking biotherapeutic platform, BioMilk.

Global Pharma | 14/06/2024 | By Aishwarya |  716

Ono Announces Acquisition of Deciphera Pharmaceuticals

Ono Pharmaceutical, Co., Ltd. has completed the tender offer to acquire all outstanding shares of common stock of a US biopharmaceutical company, Deciphera Pharmaceuticals, Inc. for USD 25.60 per share (total amount of approximately USD 2.4 billion) net to the seller in cash.

Global Pharma | 14/06/2024 | By Aishwarya |  841

Suven to Acquire Majority Stake in Sapala Organics

Suven Pharmaceuticals has signed a definitive agreement for a strategic controlling investment in Sapala Organics Private Ltd.

Global Pharma | 14/06/2024 | By Aishwarya |  768

Xeltis Bags IDE Approval from FDA for Initiation of US Pivotal Trial for aXess

Xeltis announces that it has gained approval from the US Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) submission to begin enrolling patients into a pivotal study for aXess.

Global Pharma | 13/06/2024 | By Manvi |  519

Prendio-BioProcure and Portal Innovations to Accelerate Life Science Innovation

Prendio-BioProcure has forged a strategic partnership with Portal Innovations, aimed at accelerating innovation and growth in the life science sector.

Global Pharma | 13/06/2024 | By Aishwarya |  601

Clario Announces FDA Clearance for its SpiroSphere with Wireless COR-12 ECG Device

This technological advancement allows for the consecutive collection of spirometry and ECG data during a single site visit through Clario's SpiroSphere® platform, consolidating all data into a single, unified database.

Global Pharma | 13/06/2024 | By Manvi |  738

Asahi Kasei Introduces Membrane System to Produce Water for Injection

Asahi Kasei has begun selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for the preparation of injections.

Global Pharma | 13/06/2024 | By Aishwarya |  546